Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ivanov, Iliyan S.
Schuiz, Kurt P.
Palmero, Robyn C.
and
Newcorn, Jeffrey H.
2006.
Neurorobiology and Evidence-Based Biological Treatments for Substance Abuse Disorders.
CNS Spectrums,
Vol. 11,
Issue. 11,
p.
864.
France, Charles P.
Weltman, Robert H.
Koek, Wouter
Cruź, Christopher M.
and
McMahon, Lance R.
2006.
Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): Dependence liability studies..
Behavioral Neuroscience,
Vol. 120,
Issue. 3,
p.
535.
Redfern, William
and
Wakefield, Ian
2006.
Toxicological Testing Handbook.
p.
33.
Möhler, Hanns
2007.
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors.
Journal of Neurochemistry,
Vol. 102,
Issue. 1,
p.
1.
Rowlett, James K.
Duke, Angela N.
and
Platt, Donna M.
2007.
The GABA Receptors.
p.
143.
Rowlett, James K.
2008.
Handbook of Anxiety and Fear.
Vol. 17,
Issue. ,
p.
223.
Kohut, Stephen J.
and
Ator, Nancy A.
2008.
Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023.
Pharmacology Biochemistry and Behavior,
Vol. 90,
Issue. 1,
p.
65.
Atack, John R.
2008.
GABAA Receptor Subtype‐Selective Efficacy: TPA023, an α2/α3 Selective Non‐sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer.
CNS Neuroscience & Therapeutics,
Vol. 14,
Issue. 1,
p.
25.
Knabl, Julia
Witschi, Robert
Hösl, Katharina
Reinold, Heiko
Zeilhofer, Ulrike B.
Ahmadi, Seifollah
Brockhaus, Johannes
Sergejeva, Marina
Hess, Andreas
Brune, Kay
Fritschy, Jean-Marc
Rudolph, Uwe
Möhler, Hanns
and
Zeilhofer, Hanns Ulrich
2008.
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
Nature,
Vol. 451,
Issue. 7176,
p.
330.
Atack, John R.
2008.
GABAAReceptor Subtype-Selective Efficacy: TPA023, an α2/α3 Selective Non-sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer.
CNS Neuroscience & Therapeutics,
Vol. 14,
Issue. 1,
p.
25.
Licata, Stephanie C.
and
Rowlett, James K.
2008.
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond.
Pharmacology Biochemistry and Behavior,
Vol. 90,
Issue. 1,
p.
74.
Möhler, Hanns
Rudolph, Uwe
Boison, Detlev
Singer, Philipp
Feldon, Joram
and
Yee, Benjamin K.
2008.
Regulation of cognition and symptoms of psychosis: Focus on GABAA receptors and glycine transporter 1`.
Pharmacology Biochemistry and Behavior,
Vol. 90,
Issue. 1,
p.
58.
Zeilhofer, Hanns Ulrich
Witschi, Robert
and
Johansson, Torbjörn
2009.
Synaptic Plasticity in Pain.
p.
49.
Zeilhofer, Hanns Ulrich
Möhler, Hanns
and
Di Lio, Alessandra
2009.
GABAergic analgesia: new insights from mutant mice and subtype-selective agonists.
Trends in Pharmacological Sciences,
Vol. 30,
Issue. 8,
p.
397.
D’Hulst, Charlotte
Atack, John R.
and
Kooy, R. Frank
2009.
The complexity of the GABAA receptor shapes unique pharmacological profiles.
Drug Discovery Today,
Vol. 14,
Issue. 17-18,
p.
866.
Atack, John R.
2009.
Contemporary Aspects of Biomedical Research - Drug Discovery.
Vol. 57,
Issue. ,
p.
137.
Atack, John R.
2009.
Behavioral Neurobiology of Anxiety and Its Treatment.
Vol. 2,
Issue. ,
p.
331.
Möhler, Hanns
2010.
GABA and Sleep.
p.
3.
Atack, John R.
2010.
GABA and Sleep.
p.
25.
Licata, Stephanie C.
Platt, Donna M.
Rüedi-Bettschen, Daniela
Atack, John R.
Dawson, Gerard R.
Van Linn, Michael L.
Cook, James M.
and
Rowlett, James K.
2010.
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): Role of GABAA receptor subtypes.
Neuropharmacology,
Vol. 58,
Issue. 2,
p.
357.